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Gene Regulation Displays An Enrichment Of Both Additive And Multiplicative 
Outcomes When Combining The Effects Of Two Cell Signals 
Abstract 
Cell signals often act to ultimately affect the transcription of genes, and it is common for twodifferent 
signals to affect the transcription of the same gene. In such cases, it is natural to ask how the combined 
transcriptional response compares to the individual responses. Mechanistic models can predict a range 
of combined responses, with the most commonly applied models predicting additive or multiplicative 
responses, but systematic genome-wide evaluation of these predictions have not been available. Here, we 
performed a comprehensive analysis of the transcriptional response of human MCF-7 cells to two 
different signals (retinoic acid and TGF-β), applied individually and in combination. We found that the 
combined responses exhibited a range of behaviors, but clearly favored both additive and multiplicative 
combined transcriptional responses. We also performed paired chromatin accessibility measurements, 
which previously have been shown to correlate with transcription factor occupancy at DNA regulatory 
elements. We found that increases in chromatin accessibility were largely additive, meaning that the 
accessibility response was the sum of the accessibility responses to each signal individually. We found 
some association between super-additivity of accessibility and multiplicative or super-multiplicative 
combined transcriptional responses, while sub-additivity of accessibility associated with additive 
transcriptional responses. For peaks that experienced increases in accessibility, there was a modest 
increase in the likelihood of a peak to be super-additive when it contained both a retinoic acid-associated 
transcription factor motif and a TGF-β-associated transcription factor motif. Our findings suggest that 
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ABSTRACT 
GENE REGULATION DISPLAYS AN ENRICHMENT OF BOTH ADDITIVE AND 
MULTIPLICATIVE OUTCOMES WHEN COMBINING THE EFFECTS OF TWO CELL SIGNALS 
Eric M. Sanford 
     Arjun Raj
Cell signals often act to ultimately affect the transcription of genes, and it is common for two 
different signals to affect the transcription of the same gene. In such cases, it is natural to ask 
how the combined transcriptional response compares to the individual responses. Mechanistic 
models can predict a range of combined responses, with the most commonly applied models 
predicting additive or multiplicative responses, but systematic genome-wide evaluation of these 
predictions have not been available. Here, we performed a comprehensive analysis of the 
transcriptional response of human MCF-7 cells to two different signals (retinoic acid and TGF-
β) , applied individually and in combination. We found that the combined responses exhibited a 
range of behaviors, but clearly favored both additive and multiplicative combined transcriptional 
responses. We also performed paired chromatin accessibility measurements, which previously 
have been shown to correlate with transcription factor occupancy at DNA regulatory elements. 
We found that increases in chromatin accessibility were largely additive, meaning that the 
accessibility response was the sum of the accessibility responses to each signal individually. We 
found some association between super-additivity of accessibility and multiplicative or super-
multiplicative combined transcriptional responses, while sub-additivity of accessibility associated 
with additive transcriptional responses. For peaks that experienced increases in accessibility, 
there was a modest increase in the likelihood of a peak to be super-additive when it contained 
both a retinoic acid-associated transcription factor motif and a TGF-β-associated transcription 
factor motif. Our findings suggest that mechanistic models of combined transcriptional regulation 
must be able to reproduce a range of behaviors.  
iv 
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CHAPTER 1: INTRODUCTION 
Cell signals often act to regulate transcription, and an individual signal might increase or 
decrease the expression of thousands of genes. When multiple cell signals act to increase the 
expression of the same gene, a cell must combine their effects into a single transcriptional 
response. The magnitude of this single combined response likely depends on the types of 
biophysical interactions that occur between each signal. In this thesis, I combine functional 
genomics experiments with both mathematical and computational analyses to profile how 
upregulated genes combine the effects of two cell signals, specifically retinoic acid and TGF-β. 
Such analyses may help to evaluate and constrain biophysical models of transcription that may 
one day become a central part of an “end-to-end” mechanistic model of cell signaling and its 
effect on gene regulation. 
How might we mathematically characterize a combined transcriptional response to two 
cell signals? Suppose that at baseline, a cell expresses 100 copies of mRNA of gene X. If you 
give signal A, the cell expresses 200 copies of gene X. Give signal B, and you see 300 copies. 
When both signal A and signal B are given simultaneously the effects might add (gene X 
increases to 400 copies), multiply (600 copies), or combine in some other way best described by 
more complex mathematical operations. Additive and to some extent multiplicative 
phenomenological models have been widely used, in part due to their emergence from simple 
mechanistic models of transcriptional regulation. However, there is little systematic empirical 
evidence that either of these phenomenological models of combined responses are in general 
valid or should be favored in any way. 
Additive combined transcriptional responses naturally emerge from a model in which 
transcription factors can independently recruit polymerase to the promoter (Scholes, DePace, and 
Sánchez 2017; Bothma et al. 2015; Bender et al. 2012). Specifically, if signal A and signal B each 
induce the binding of different transcription factors to the enhancers of gene X, and these each 
independently result in an increased rate of binding of the polymerase to the promoter, then the 
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total rate of binding would be the sum of the two independent contributions. A key assumption in 
this mechanistic model is that the rate of transcription is accurately described by the rate of 
polymerase binding to the promoter, and thus transcriptional regulation can be effectively 
summarized by a one-step biochemical process (Scholes, DePace, and Sánchez 2017; Bothma 
et al. 2015; Bender et al. 2012). (This additive prediction also assumes that the binding events 
are not so frequent as to saturate the promoter ((Scholes, DePace, and Sánchez 2017; Bothma 
et al. 2015; Bender et al. 2012)).) Additive combined transcriptional responses have also been 
hypothesized to occur when signals act at distinct enhancers that independently interact with the 
promoter. Consistent with this behavior, the deletion of pairs of enhancers at the mouse β-globin 
locus resulted in additive reductions in gene expression (Bender et al. 2012), and CRISPRa-
based activation of enhancer subsets resulted in additive increases in gene expression for 
several genes in an endometrial cancer cell line (Ginley-Hidinger et al. 2019). However, these 
experiments are typically limited to small sets of genes, making it difficult to conclude that additive 
behavior is the default, and indeed deviations from additive behavior are prevalent (Bothma et al. 
2015; Ginley-Hidinger et al. 2019; Scholes et al. 2019).  
Multiplicative combined transcriptional responses are hypothesized to occur under an oft-
cited model of transcriptional regulation, commonly known as the thermodynamic model (Ackers, 
Johnson, and Shea 1982; Bintu et al. 2005; Phillips et al. 2019; Sherman and Cohen 2012; 
Scholes, DePace, and Sánchez 2017). In the thermodynamic model, it is assumed that 
equilibrium binding levels of RNA polymerase to the promoter is the key control point for 
transcriptional regulation. The thermodynamic model uses a mathematical framework from the 
field of statistical mechanics, in which every possible state of promoter and enhancer occupancy 
by transcription factors is enumerated and has an associated energy value. Each state’s energy 
value depends on how many favorable versus unfavorable binding interactions it has, where 
favorable binding interactions result in lower energy ((Ackers, Johnson, and Shea 1982; Bintu et 
al. 2005; Phillips et al. 2019; Sherman and Cohen 2012; Scholes, DePace, and Sánchez 2017)). 
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One such favorable interaction might be binding between a transcription factor, its DNA motif, and 
RNA polymerase. Each state is given a probability that depends on the sum of the energy of each 
of its interactions. This probability is proportional to its Boltzmann weight, in which there is an 
exponential relation between a state’s total energy and its relative probability, where more 
negative energy values are exponentially more likely to occur. Formally, the probability of a state 
i, pi, is directly proportional to e-ε, where ε represents the total energy of state i.  
In a simple instantiation of a thermodynamic model with one promoter and two 
transcription factors, A’ and B’, that mediate the effects of signals A and B on gene X, each factor 
individually lowers the binding energy of RNA polymerase to the promoter, increasing its affinity 
(Bintu et al. 2005). If both transcription factors are present, then the changes in binding energy 
add, and hence, given that the probability of a transcription factor recruiting RNA polymerase II 
depends exponentially on binding energy, the net change in equilibrium binding levels of RNA 
polymerase II would multiply. This prediction of multiplicative combined transcriptional responses 
extends to more complex instantiations of the thermodynamic model, in which signals A and B 
increase the activity of distinct sets of transcription factors that do not directly bind to each other 
or interfere with each other’s binding to DNA or to RNA polymerase. When binding interactions 
between transcription factors are included in the thermodynamic model, it leads to predictions of 
combined transcriptional responses that are either super-multiplicative or sub-multiplicative. Thus, 
in the “default” case, a thermodynamic model of transcriptional regulation predicts that the 
transcriptional effects of two signals will multiply when both signals are given simultaneously. 
Multiplicative activation by two RNA polymerase-binding factors has been seen in mutant 
E. coli experiments after λcI and CRP binding sides were placed adjacent to a lacZ promoter 
(Joung, Koepp, and Hochschild 1994). In eukaryotes, thermodynamic models have been 
successful in predicting how engineered combinations of a few known transcription factor binding 
sequences next to a promoter affect the transcription of reporter genes in yeast and mouse 
embryonic stem cells, explaining ~50% of the variance in reporter gene expression, and up to 
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72% of the variance when non-multiplicative interaction terms are included (Gertz, Siggia, and 
Cohen 2009; Fiore and Cohen 2016). However, it is unclear from many of these assays, most of 
which focus on promoter manipulations, how prevalent and general the multiplicative predictions 
of the simplest version of the thermodynamic model are, especially given that many combined 
responses are known to follow more simple additive predictions (Bender et al. 2012; Ginley-
Hidinger et al. 2019). 
While potential mechanisms underlying additive and multiplicative behavior are 
straightforward, there is no a priori reason to believe that most genes would follow one or the 
other, or either at all. Indeed, a larger class of “kinetic” models of transcription have been shown 
to admit a wide variety of behaviors, ranging from sub-addition to super-multiplication (Scholes, 
DePace, and Sánchez 2017). Kinetic models describe transcription as a series of steps, each 
with independent rates, that must occur in series before an mRNA molecule is successfully 
produced (such steps in practice might include chromatin opening, polymerase binding, and 
polymerase pause release). Depending on the total number of steps and the locations at which 
signal-induced activators or repressors act, kinetic models can predict a wide range of combined 
transcriptional response outcomes ranging from sub-additive to super-multiplicative (Scholes, 
DePace, and Sánchez 2017). (Of note, if a kinetic model with only one step of transcription 
predicts perfectly additive outcomes.) A systematic test of these different phenomenological types 
of combined responses has yet to be done, in part because there is a lack of transcriptome-wide 
experiments in the literature that treat cells with two signals both individually and in combination. 
(A notable exception is (Goldstein et al. 2017), where the authors use dual-signal treatment and a 
heuristic approach to find synergistic and antagonistic genes but do not compare underlying 
phenomenological models of combined responses.) Thus, it remains unknown if combinatorial 
gene regulation is primarily additive, multiplicative, or a wide distribution of everything in between 
(and beyond).  
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Upstream of transcription, it is also unclear how multiple signals coordinately affect 
transcription factor binding activity at cis-regulatory elements. For instance, if each signal results 
in the binding of a specific set of transcription factors at a particular regulatory region individually, 
then do these two different sets of factors bind with the same probability when both signals are 
applied? Or are these probabilities affected by potential regulatory interactions between the 
signals? And how might these binding probabilities and potential interactions affect expression of 
the target genes? There is only limited transcription factor binding data available for experiments 
where cells receive multiple signals simultaneously (Goldstein et al. 2017), and then using ChIP-
seq, which only reports binding profiles for specific transcription factors. Pairing combined 
response experiments with chromatin accessibility measurements, which correlate with aggregate 
transcription factor binding data (Thurman et al. 2012), has the potential to answer these 
questions in a more comprehensive manner than ChIP-seq would allow for. 
Compared to transcription, little theoretical work has been done to make quantitative 
predictions for how chromatin accessibility might change at regulatory elements affected by 
multiple input signals. Several mechanisms have been proposed for how closed chromatin might 
be opened. These mechanisms include displacement of nucleosomes by pioneer transcription 
factors (Zaret and Carroll 2011), recruitment of secondary factors by primary transcription factors, 
or recruitment of chromatin remodeling complexes by primary transcription factors (Klemm, 
Shipony, and Greenleaf 2019). Each of these mechanisms, however, do not currently have 
associated mathematical predictions for how chromatin accessibility data, as measured by ATAC-
seq, might quantitatively change in response to combinatorial signal treatment. This may be in 
part due to the fact that chromatin accessibility data does not have the same straightforward 
interpretation as gene expression data, which is directly proportional to the abundance of mRNA 
molecules. Nevertheless, in chapter 3 we show how we might expect increases in chromatin 
accessibility to be additive in the case when each signal’s induced factors work independently to 
open chromatin and do so only rarely. Deviations from additive changes in accessibility might 
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represent either saturation of a cis-regulatory element or favorable interactions between each 
signal’s induced transcription factors and chromatin remodeling complexes. 
Experimentally, part of what makes it difficult to compare phenomenological models of 
combined responses is that additive and multiplicative models can give nearly indistinguishable 
predictions, especially when one or both of the signals’ effects are relatively small. As such, often 
experimental data will be consistent with, say, a multiplicative or additive model (or weighted 
variants of such models), but it is difficult to exclude the possibility of the other model, especially 
when only a limited number of genes are considered (Rothschild et al. 2014; Kaplan et al. 2008; 
Geva-Zatorsky et al. 2010; Rapakoulia et al. 2017). With current genome-wide expression 
profiling tools, however, it may be possible to query the integration modes of sufficiently many 
genes so as to discriminate between additive, multiplicative, and other phenomenological model 
predictions for at least some subset of genes, thus enabling a larger scale view of gene 
regulation’s tendencies towards specific combined response behaviors. 
How might we systematically compare how well addition, multiplication, or other 
mathematical operations best capture the observed range of combined transcriptional 
responses? It turns out that the difference between an additive combined response and a 
multiplicative combined response can be readily summarized in a single mathematical term (we 
derive this term in Box 1). This term enables us to create a mathematical continuum that spans 
sub-additive, addition, multiplication, and super-multiplication. To create this continuum, we 
define a mathematical term, the combined response factor, which multiplies the difference term 
between addition and multiplication (see Box 1). The combined response factor can be exactly 
calculated when both individual and combined transcriptional effects of two signals are measured, 
and the value of this term directly maps to the categories of sub-addition, addition, multiplication, 
and super-multiplication. Other more abstract mathematical continuums spanning addition and 
multiplication have also been proposed (Crespo and Montáns 2016), in which a “hyperoperation” 
between two numbers has a value of 1 if the operation is addition, 2 if the operation is 
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multiplication, and 3 if the operation in exponentiation, with intermediate operations being 
possible (interestingly, any hyperoperation acting on 2 and 2 is always 4 regardless of the 
hyperoperation’s value (Crespo and Montáns 2016)). However, hyperoperations of different 
values have different mathematical properties that are not readily predicted a priori, and the lack 
of guaranteed “symmetry” alone (in the case of exponentiation, ab does not necessarily equal ba) 
renders the hyperoperation framework unsuitable for our question. 
In this thesis, I profiled MCF-7 cells with paired RNA-seq and ATAC-seq measurements 
after exposing them to retinoic acid, TGF-β, and both signals. I found that while genes’ 
transcriptional responses exhibit a wide variety of behaviors when combining the effects of these 
two signals, they generally tended towards either addition or multiplication when both signals 
individually caused increases in expression. Upregulated ATAC-seq peaks, on the other hand, 
appeared to prefer addition as the default operation for combining two signal effects, although a 
minority of peaks clearly showed sub-additive or super-additive behavior. Genes with super-
additive ATAC-seq peaks nearby were more likely to have a multiplicative or super-multiplicative 
transcriptional responses to retinoic acid and TGF-β. These data and analyses provide a 












CHAPTER 2: UPREGULATED GENES GRAVITATE TOWARDS EITHER ADDITION OR 
MULTIPLICATION WHEN COMBINING THE TRANSCRIPTIONAL EFFECTS OF RETINOIC 
ACID AND TGF-β 
 Multiple cell signals often converge to affect the transcription of the same gene, but it 
remains unknown how multiple cell signals combine their effects into a single transcriptional 
response, and there has been a lack of genome-wide, systematic analyses to address this 
question. In this chapter we describe how we designed an experiment to measure the 
transcriptional effects of retinoic acid, TGF-β, and both signals applied in combination at multiple 
doses to assess combined transcriptional responses in human MCF-7 cells in a genome-wide 
manner. We then perform a series of analyses that suggest additive and multiplicative combined 
signal responses are favored over other types of combined responses.  
Design of combined signal treatment experiments with paired gene expression and chromatin 
accessibility profiling 
To quantitatively measure how gene regulation depends on multiple input signals, we 
performed three replicates of a paired RNA-seq and ATAC-seq experiment using MCF-7 cells 
(human breast carcinoma; selected for being well-characterized in its response to the two signals 
chosen). Prior to sequencing, we treated these cells with three different doses of TGF-β (1.25, 5, 
and 10 ng/ml), retinoic acid (50, 200, and 400 nM), or both signals (low, medium, and high 
dosages of both TGF-β and retinoic acid simultaneously) for 72 hours (Figure 1B). We waited 72 
hours to create a larger set of differentially expressed genes to use in subsequent analyses, and 
chose doses that led to broad changes in transcription and chromatin accessibility (Figure 1B; 
see methods for discussion of doses chosen). Initial analysis showed that the number of 
differentially expressed genes and differential peaks increased in a dose-dependent manner, and 
that all genes that were upregulated in both individual signal treatments were also upregulated in 
the combination treatment (Figure 1B). We focused our analysis on upregulated genes and 
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upregulated ATAC-seq peaks due to their greater dynamic range in effect sizes and their more 
straightforward interpretation in the context of potential binding of activators to increase the 
transcription of nearby genes. (Note that our ethanol “vehicle” controls were performed at three 
different cell concentrations, and there were no significantly differentially expressed genes 
between concentrations. We did not, however, add the signals to different concentrations of cells 
or cells at different points in the cell cycle, in which context the signals may exert differential 
effects.) 
Definition of the master set of upregulated genes used for further analysis 
We defined a master set of 1,398 genes by selecting the set of genes that were 
significantly upregulated in any dose of the combination treatment (log2 fold-change ≥ 0.5 and 
Benjamini-Hochberg adjusted p value ≤ 0.05) and that had increased expression in all doses of 
each individual signal (Figure 1D). If we had selected the full set of all genes upregulated in any 
dose of the combined treatment, we would have analyzed a set of 2246 genes (Figure 1D). We 
required the change in expression to be positive for both individual signals, however, (i.e., ΔA > 0 
and ΔB > 0) in order to maintain a consistent mapping between our categorical description of 
combined responses (e.g., “sub-additive”, “super-multiplicative” (Figure 2)) and our continuous “c 
value” description of combined responses defined in Box 1 and Figure 1A. Requiring ΔA > 0 and 
ΔB > 0 in our master set of genes was necessary to guarantee that sub-additive combined 
transcriptional responses always had c values less than 0 and that super-multiplicative responses 
always had c values greater than 1. Imposing the conditions of ΔA > 0 and ΔB > 0 removed 
37.8% of the 2,246 genes that showed a significant increase in expression in the combined 
treatment (Figure 1D), leaving 1396 of the 1398 genes that ultimately fed into our analyses. 
Inclusion of genes with negative changes after individual signal treatments would require a more 
elaborate analysis framework to encompass the much larger variety of categorizations of 
potential responses that would be difficult to characterize with the number of genes in our 
analysis. (There were only two genes that were significantly downregulated in the combined 
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treatment while also having ΔA > 0 and ΔB > 0 at all doses of each individual signal treatment; 
we elected to also include these two genes in our master set for the total of 1398.) 
Retinoic acid and TGF-β likely affect the activity of distinct groups of transcription factors 
In our analysis of combined transcriptional responses, we assumed that retinoic acid and 
TGF-β exhibited their effects on common target genes through distinct transcription factors. To 
justify this assumption, we confirmed that there was little cross-activation of pSMAD2 (which 
serves as a proxy for the readout of TGF-β signaling) by performing immunofluorescence 
targeting pSMAD2 upon the addition of TGF-β and retinoic acid individually (Figure 3A-B). We 
saw that TGF-β treatment rapidly increased the nuclear signal of pSMAD2 (by 40 minutes), which 
remained above baseline until the final time point at 72 hours, whereas retinoic acid treatment 
induced no changes in pSMAD2 signal relative to baseline (Figure 3C-E). Nuclear expression of 
retinoic acid receptor alpha, which resides in the nucleus regardless of activation level 
(Mangelsdorf and Evans 1995), was stable between conditions at all time points (Figure 4). 
Subsequent transcription factor motif analysis of our ATAC-seq data, however, suggested that 
retinoic acid receptor alpha (RARA) is activated by retinoic acid and not TGF-β (See section titled 
“Motif analysis reveals that sub-additive peaks have a depletion of AP-1 and an enrichment of 
CTCF motifs while super-additive peaks have an enrichment of SMAD motifs“). This same motif 
analysis also suggested that retinoic acid and TGF-β largely increased the activity of distinct 
transcription factors at the 72 hour time point, meaning that the secondary effects of retinoic acid 
and TGF-β are likely mediated through the activity of distinct transcription factors. 
Statistical classification of upregulated genes shows significant amounts of sub-additive, additive, 
multiplicative, and super-multiplicative combined transcriptional responses 
Within our master set of 1,398 upregulated genes, we found a variety of different 
combined transcriptional response behaviors ranging from sub-addition to super-multiplication 
(Figure 1D-F). A transcriptional response is additive when the combined treatment effect 
12 
 
represents the sum of the individual treatment effects, and multiplicative when the combined 
treatment represents the product of the individual treatment fold-changes. When both signals 
upregulate the expression of a gene, a multiplicative response is always higher than an additive 
response (Box 1; Figure 1A). To systematically classify the combined transcriptional responses at 
each gene, we used a statistical approach where we assumed each observation of a gene’s 
expression value was derived from a Gaussian distribution (see methods). We classified a 
combined transcriptional response as sub-additive, additive, multiplicative, or super-multiplicative 
by comparing where a “perfect” hypothetical additive or multiplicative response lay with respect to 
the 80% confidence interval of the combined treatment's expression value (Figure 2B). If both the 
hypothetical additive and the hypothetical multiplicative predictions lay within the confidence 
interval, we classified the response as ambiguous (Figure 2B). Using this approach, we found 
that at the medium dose, 8.7% of genes had sub-additive combined transcriptional responses, 
15.1% had additive responses, 2.1% had between an additive and multiplicative response, 11.7% 
had multiplicative responses, 18.7% had super-multiplicative responses, and 43.7% had 
ambiguous responses (Figure 1D), suggesting there is no single dominant category of combined 
response behavior. However, while the categories of addition and multiplication are appealing 
due to their correspondence to these simple phenomenological models, there is no a priori 
reason to believe that all or even most genes should necessarily adhere to either of these 
possibilities. 
“Pure” addition and multiplication are enriched types of combined transcriptional responses  
 In order to quantitatively describe the combined transcriptional response characteristics 
of any gene without any presupposition of additive or multiplicative behavior, we defined a 
continuous parameter, hereby referred to as a gene’s combined response factor or “c” value, that 
places the gene in an exact location on the spectrum of possible combined response behaviors 
(Box 1; Figure 1A). We could then solve for any gene’s c value (within experimental error) after 
measuring the individual signal effects and the combined treatment effect. For an upregulated 
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gene, a c value of 0 would indicate perfect addition, a c value of 1 indicates perfect multiplication, 
a c value less than 0 indicates sub-addition, and a c value greater than 1 indicates super-
multiplication (see Figure 1A for equation). We wondered what the distribution of c values would 
look like across our master set of upregulated genes, and whether this distribution would tell us 
anything about genes’ natural inclinations for specific combined response behaviors. For 
instance, if this distribution had its main peak at c = 0.5, it would imply that genes naturally prefer 
to integrate two signals in a manner that lies between addition and multiplication. At all doses of 
combination treatment, we observed a wide peak centered around c=0 (additive), with a hint of a 
secondary peak at c=1 (multiplicative), suggesting that the integration of the effects of two signals 
is preferentially additive or multiplicative (Figure 1F; Figure 5)). 
In order to more rigorously demonstrate the preferences for these two values of c, we 
performed a series of simulations and statistical analyses. First, we generated simulated data 
taking into account measurement noise to estimate what the expected distributions of c would 
look like if signal integration was wholly additive or multiplicative. For each gene, we made three 
random draws for expression levels in both signal conditions based on the actual expression 
measurements and variance of those measurements to mimic our actual data (Figure 2C). We 
then computed what we would have measured c to be based on these simulated measurements. 
This “null” produced broad peaks centered around c=0 and c=1, respectively, and a superposition 
of these two nulls appeared to match our experimentally measured distribution of c values (Figure 
1F). In order to more clearly demonstrate the existence of a secondary peak at c=1, we 
subtracted off from the distribution a purely additive null model (as computed above, fit to the 
observed distribution). The resultant residual distribution was a broad peak centered roughly 
around c=1 (a Gaussian fit to the residual gave a fit centered at c=1.12 and c=1.00 at medium 
and high doses, respectively), consistent with our multiplicative simulated data (Figure 1F; Figure 
5A). We showed that this residual distribution was not likely to be due to statistical fluctuations by 
computing a p-value for the possibility of obtaining as big a residual in a sliding window by 
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random chance (Figure 5B). Overall, while there is the possibility of further peaks within our data, 
our data most strongly support the existence of two peaks in the c-value histogram, one 
corresponding most closely with an additive model, and the other with a multiplicative model. 
While our superimposed distribution of c values derived from simulated additive and multiplicative 
combined responses bears a close resemblance to our observed distribution of c values in the 
neighborhoods of c = 0 (addition) and c = 1 (multiplication), the tails of the observed c value 
distribution are clearly heavier (Figure 1F). These heavier tails illustrate that biological variation, 
rather than measurement error, produces a significant amount of sub-additive (c < 0) and super-
multiplicative (c > 1) combined transcriptional responses.  
We next wondered how a gene’s combined response factor (c value) depended on 
dosage of the input signals. In theory, the c value might remain stable as dosage increases, 
monotonically increase or decrease as dosage increases, or may appear to be “random” with 
respect to dose, perhaps due to complex unobserved dose-dependent gene regulatory 
interactions. To distinguish between these possibilities, we plotted how a set of upregulated 
genes’ c values changed as they moved from low to medium to high dose of combination 
treatment with retinoic acid and TGF-β (Figure 6B-D). To generate a subset of reliable c value 
estimates within our master set of genes, we selected genes for which  ≥ 2 transcripts per 
million (TPM) and   ≥ xbaseline (Figure 6C). Since  captures the difference between the 
multiplicative and additive predictions, the estimation of c is more reliable when  is large, 
because when that number is large it is less susceptible to technical variability. We found that 
most genes’ c values were stable or moderately decreased with increasing signal dose, 
suggesting that the function a gene uses to combine two signals is mostly stable, with a tendency 
towards “saturation” with increasing dose (i.e., the function itself moves in the direction of sub-
additivity when dosage increases).  
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Figure 1: Addition and multiplication are enriched modes of signal integration in 




Figure 1: A. Example of additive vs. multiplicative effects on expression of hypothetical gene X, 
mathematical formulation of the combined response factor, and illustration of how the value of the 
combined response factor (c value) reflects whether a combined gene expression response is 
sub-additive, additive, multiplicative, or super-multiplicative. B. Schematic of signal response 
experiments in MCF-7 cells. Briefly, we treated MCF-7 cells with three different dosages of 
retinoic acid, TGF-β, or both signals for 72 hours, then performed bulk RNA-seq and ATAC-seq 
at the endpoint. We show the number of differentially expressed genes and peaks for each dose 
of each condition as well as the overlap between the sets of differentially expressed genes and 
differential peaks. C. Five example genes representing sub-additive to super-multiplicative 
combined transcriptional responses, where we show each gene’s transcripts per million (TPM) 
value for each replicate after single or combined signal treatments. Horizontal grey bars show the 
average TPM value, and error bars represent the 80% confidence interval of the estimated 
underlying Gaussian distribution of each dosage and condition (see Methods for parameter 
estimation details). D. Illustrated definition of master set of upregulated genes. E. Frequency of 
each type of combined response behavior for each dosage in the master set of genes. F. 
Simulated, observed, and residual histograms of c value distributions for the medium and high 
doses. In the simulated mixture model, we randomly simulated combined responses to be either 
additive or multiplicative based on the relative frequency of additive vs. multiplicative combined 
transcriptional responses that we observed at each dose in 1E. Annotated percentages at broken 
bars represent the fraction of c values in the tail beyond the limits of the x axis of the graph. *For 
all c value analyses, 14 genes with a control TPM of zero were removed from the master set of 
genes, as they end up misleadingly having c values of exactly 0 regardless of the effects of 
retinoic acid and TGF-β.  
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Figure 2: Explanatory schematics for model of gene expression variation, classification of 





Figure 2: A. Schematic illustrating how we estimate the 80% confidence interval of a Gaussian 
distribution underlying our gene expression measurements. B. Illustration of how we use the 80% 
confidence interval to classify combined responses in Figure 1E as sub-additive, additive, 
multiplicative, super-multiplicative, or ambiguous. C. Diagram showing how we simulate new 
observations by using the Gaussian distributions we estimated to underlie each condition and 
dose’s gene expression measurements. D. Schematic showing how we combine many simulated 
combined responses from each gene in our master set (*less any gene with a control TPM 
measurement of 0) to create a new distribution of simulated c values. E. Example genes 
illustrating how the variance of a gene expression measurement often depends on the signal(s) 
given. F. Correlation matrix showing the Pearson correlation between coefficient of variation (CV) 
estimates between each condition, with black boxes outlining correlations between different 
doses of the same signal(s). 
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Figure 3: A. Schematic describing immunofluorescence experiment design. B. Example images 
of RARA immunofluorescence for each condition (medium dose of retinoic acid, TGF-β, or 
control) at each time point. C. Computational analysis workflow schematic, which describes how 
we use the Cellpose segmentation algorithm in the DAPI channel to identify nuclear boundaries 
for measuring average nuclear signal intensity in the RARA immunofluorescence channel. D. 
Summary statistics of normalized RARA nuclear intensity, where each point represents the 




Figure 4: Nuclear retinoic acid receptor alpha levels are stable across treatment conditions  
 
Figure 4: A. Schematic describing immunofluorescence experiment design. B. Example images 
of RARA immunofluorescence for each condition (medium dose of retinoic acid, TGF-β, or 
control) at each time point. C. Computational analysis workflow schematic, which describes how 
we use the Cellpose segmentation algorithm in the DAPI channel to identify nuclear boundaries 
for measuring average nuclear signal intensity in the RARA immunofluorescence channel. D. 
Summary statistics of normalized RARA nuclear intensity, where each point represents the 




Figure 5: A secondary peak occurs at or near perfectly multiplicative combined 
transcriptional responses (c = 1) after subtracting a distribution of simulated additive 




Figure 5: A. For each dose, the observed c value distribution (in the range from c = -4 to c = 5), 
simulated c value distribution when transcriptional responses are assumed to be either additive or 
multiplicative, and residual distributions after the additive component of the simulated data is 
subtracted. Blue lines illustrate the best-fit Gaussian to the residual distribution (see Methods for 
details). B. At each dose, a c value distribution generated by simulated additive responses is 
matched to the height of the peak at c = 0 in the observed data. Then, the probability of 
witnessing the number of combined responses in each of the bins in the observed histogram is 
estimated under the null model that all combined responses are additive. Due to the limits of 
computational power and the extremely low probabilities of witnessing the number of 
observations as the bins move further away from c = 0, we assumed Poisson distribution was 
descriptive of the number of simulated observations that lied in a given c value bin (this 
assumption is justified by panel C, where the mean and variance of the number of simulated 
responses in each bin are nearly identical outside the narrow range of  -0.3 < c < 0.3). C. At each 





Figure 6: The combined response factor tends to remain stable or decrease with 
increasing signal dosage 
 
Figure 6: A. Mathematical expression showing how we determine the value of the combined 
response factor (c value) for a given gene and signal dosage. TPM = transcripts per million. B. 
Histograms illustrating the distribution of c value changes as dosage increases. C. Same 
histograms as in B, focusing on a subset of genes with stable c value estimates. D. Sparklines 
showing the c value at low, medium, and high dosage for each gene in the subset of genes 
outlined in panel C.   
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CHAPTER 3: INCREASES IN CHROMATIN ACCESSIBILITY ARE LARGELY ADDITIVE, AND 
DEVIATIONS FROM ADDITIVITY ARE ASSOCIATED WITH SPECIFIC TYPES OF COMBINED 
TRANSCRIPTIONAL RESPONSES 
 Signals are believed to largely affect transcription of genes through their actions on 
transcription factors, which bind to DNA at cis-regulatory elements. When two signals act to 
increase chromatin accessibility at the same cis-regulatory element, it is largely unknown how 
their effects might combine. In this chapter we show that the “default” operation for two signals 
increasing chromatin accessibility is addition. However, there are significant amounts of ATAC-
seq peaks that display sub-additive and super-additive integration of both signal effects, with sub-
additive peaks being more likely to be found near genes with additive combined transcriptional 
responses and super-additive peaks being more likely to be found near genes with multiplicative 
or super-multiplicative combined transcriptional responses 
Transcription factor motif analysis shows expected enrichment of RARA motifs in retinoic acid 
treated conditions and SMAD motifs in TGF-β treated conditions 
 Transcriptional regulation is thought to occur largely via the binding of transcription 
factors, but it remains unknown how the transcription factors associated with the effects of 
individual signals might interact upon the addition of both signals simultaneously. We performed 
ATAC-seq on the same populations described earlier, reasoning that the observation that 
changes in chromatin accessibility have been shown to correlate with changes in aggregate 
transcription factor binding activity (Thurman et al., 2012) meant that we could infer something 
about transcription factor binding at these sites. Note that the extent to which changes in 
chromatin accessibility quantitatively reflect changes in transcription factor occupancy is currently 
unknown, and may depend on the mechanism by which binding of transcription factors leads to 
opening of chromatin, such as displacement of nucleosomes by pioneer factors, recruitment of 
secondary transcription factors, or recruitment of chromatin remodeling complexes (Zaret and 
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Carroll 2011; Klemm et al. 2019). Reassuringly, our initial motif enrichment analysis revealed that 
retinoic acid receptor alpha (RARA) and three TGF-β pathway transcription factor motifs 
(SMAD3, SMAD4, and SMAD9) were highly enriched in their respective individual signal 
treatment conditions (Figure 11B). Note that our motif analysis also indicated some degree of 
activation of RARA by TGF-β and some degree of activation of SMAD3 and SMAD9 by retinoic 
acid, which led to even higher enrichment levels of these factors in the combined treatment 
condition (Figure 11A). We did not, however, observe cross-activation of pSMAD2 by retinoic acid 
in immunofluorescence experiments (Figure 3). 
Upregulated ATAC-seq peaks usually demonstrate additive integration of the two signal effects, 
but there are also significant amounts of sub-additive and super-additive peaks 
We then wondered how well simple additive and multiplicative phenomenological 
predictions corresponded to the increase in chromatin accessibility at upregulated peaks in the 
combined treatment. We found that an additive model was generally highly predictive and 
matched the observed increases in ATAC-seq fragment counts more accurately than the 
multiplicative model; the multiplicative model generally predicted larger changes in accessibility 
than we experimentally observed (Figure 8). To quantify the degree to which the additive 
prediction was accurate, we defined a new metric, the fold-change difference in accessibility from 
an additive model prediction, hereby referred to as a peak’s “d” value, to create a distribution that 
illustrates the extent to which the size of a peak in the combination treatment condition deviated 
from additive model predictions (Figure 7A-B). We found that at upregulated peaks, our observed 
distribution of d values was centered at zero, highlighting how addition appears to be the “default” 
operation at upregulated peaks (Figure 7C). This default additive behavior may correspond to a 
mechanistic model in which each signal stimulates an independent set of chromatin-opening 
transcription factors that independently and rarely bind DNA (Figure 7E). 
Given the general accuracy of the additive model for upregulated peaks, we wondered to 
what extent deviations from additive model predictions represented true deviations as opposed to 
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just measurement error. We produced randomly generated simulated data that matched the 
statistical properties of our actual data, assuming that the combined treatment would result on 
average in perfectly additive peak sizes (see methods for details). We found that our observed 
data are more widely dispersed than the simulations, indicating that a fair number of peaks are 
significantly sub-additive or super-additive (Figure 7C). We found that 19% of peaks were sub-
additive and 16% of peaks were super-additive when we considered additive peaks to be those 
where a perfectly additive prediction lied within the 80% confidence interval of the measured peak 
fragment counts (Figure 7D). Thus, most upregulated ATAC-seq peaks displayed additive or 
near-additive combined responses, but significant fractions of peaks also displayed both sub-
additive and super-additive combined responses.  
Super-additive peaks and pairs of individual signal-dominant peaks are more likely to be found 
near genes with multiplicative transcriptional responses 
 We next wondered if we could uncover the patterns of cis-regulatory element activity that 
may dictate how a gene’s regulatory behavior would encode the observed integration of the 
transcriptional effects of two signals. We reasoned that the number of upregulated ATAC-seq 
peaks near a gene or the manner in which the nearby peaks themselves integrated the two 
signals’ effects may predict the gene’s combined transcriptional response behavior. For each 
transcriptionally upregulated gene, we counted the number of sub-additive, additive, and super-
additive ATAC-seq peaks within 100 kb of its transcription start site. We found that, on average, 
genes that were transcriptionally additive had 2.7x more sub-additive ATAC-seq peaks nearby 
than genes with multiplicative transcriptional responses (medium dose, p = 0.0012). Genes with 
multiplicative and super-multiplicative transcriptional responses had 2.5x or 2.6x, respectively, 
more super-additive ATAC-seq peaks nearby than genes with additive transcriptional responses 
(Figure 9A, medium dose, p = 0.0016 or p = 0.00016, respectively). Genes with multiplicative 
transcriptional responses also had more additive ATAC-seq peaks nearby than every other 
combined transcriptional response behavior at each dose we tested, with 1.3x more additive 
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peaks than genes with additive transcriptional responses (Figure 9A, medium dose, p = 0.12 
compared to additive transcriptional responses, p = 0.00089 compared to ambiguous 
transcriptional responses). The most prominent effect in this analysis was the observation that 
super-additive peaks are more likely to be near genes with multiplicative and super-multiplicative 
transcriptional responses, suggesting that cooperative interactions between transcription factors 
at neighboring enhancers may increase the expression of a gene when both signals are added 
together; i.e., the gene’s combined response factor. 
Genes with nearby peaks exclusively responding to either retinoic acid or TGF-β are more likely 
to demonstrate multiplicative combined transcriptional responses 
 When both signals affect accessibility at the same region of DNA, interactions between 
each signal’s induced transcription factors and associated complexes can make it difficult to 
discriminate between mechanistic models of how transcription factors interact to regulate 
transcription. However, if the transcription factors affected by retinoic acid or TGF-β bind to 
distinct regions of DNA around the same gene, then there are likely no interactions between 
induced transcription factors and one can in principle discriminate between a simple 
thermodynamic model (prediction: multiplicative transcriptional effects) and an independent 
recruitment model (prediction: additive transcriptional effects). To increase the likelihood of 
selecting retinoic acid and TGF-β-exclusive transcription factor binding events, we searched near 
genes for upregulated peaks that responded exclusively to either retinoic acid or TGF-β. (We 
defined “exclusive” here to mean that the peak size increase for a single signal was ≥90% that of 
the sum of the absolute peak size changes from both individual signals. Note that to generate a 
sufficiently large sample, we had to allow the selected genes to have non-exclusive peaks nearby 
as well because only 8.0% of gene-adjacent differential peaks met this exclusivity criteria for 
retinoic acid and only 3.4% met this criteria for TGF-β.) We then considered how likely genes with 
different combined transcriptional response behaviors were to have at least one retinoic acid-
dominant and one TGF-β-dominant peak nearby (<100 kb to the transcription start site). We 
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found that at each dose, genes with multiplicative transcriptional responses were the most likely 
to have at least one retinoic-acid-dominant and one TGF-β-dominant upregulated peak nearby 
(Figure 9B; 2.4x increase compared to genes with additive transcriptional responses at high dose, 
p = 0.044), suggesting that the effects of independently-upregulated peaks are most likely to act 
together to multiplicatively regulate transcription, which is more consistent with the predictions of 
the thermodynamic model. 
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Figure 7: Addition is the default operation at upregulated differential peaks. 
 
Figure 7: A. Example tracks of ATAC-seq data. Tracks illustrate the ATAC-seq fragment counts 
per million, with each value representing the average number of fragment ends per million within 
75 bp of a given genomic coordinate. Annotated peak values represent the peak integral (the total 
number of normalized fragment counts measured within the peak), which we use to calculate the 
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peak’s d value. B. Schematic illustrating examples of two peak’s d values, where each d value 
represents the fold-change difference between the measured number of ATAC-seq counts in the 
combination treatment and the predicted number of ATAC-seq fragment counts when using an 
additive model. C. Expected vs. observed distributions of the fold-change difference from an 
additive prediction for each peak. We generated the expected distribution by simulating 10 new 
observations for each peak from the distributions we estimated our original upregulated peaks to 
have come from, setting the mean of the combined treatment to a perfectly additive prediction 
(Methods). D. Classification of ATAC-seq peaks that were upregulated individually by retinoic 
acid and TGF-β. We considered a given peak to be additive when the additive model prediction 
lied within the 80% confidence interval of our estimated distribution of the given peak’s 
normalized fragment counts in the combined treatment condition. E. Schematic illustrating how 






Figure 8: The combined response of peaks upregulated individually by retinoic acid and 




Figure 8: For each dose, histograms of the difference between the observed normalized 
fragment counts at each upregulated peak and their respective additive or multiplicative 
predictions. The observed differences are centered at zero for the main probability mass for the 
additive model but not for the multiplicative model. 
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Figure 9: Super-additive ATAC-seq peaks are enriched near genes with multiplicative and 




Figure 9: A. For each type of combined gene expression response, we show the average 
number of upregulated sub-additive, additive, and super-additive ATAC-seq peaks within 100 kb 
of the gene’s transcription start site. B. For each combined transcriptional response behavior, we 
show the percentage of genes that have at least one peak that responds exclusively to retinoic 
acid and at least one peak that responds exclusively to TGF-β (where both peaks must lie within 
100 kb of the gene’s transcription start site). For an upregulated peak to be considered a mutually 
exclusive response, the change in ATAC-seq fragment counts in the individual treatment 
condition must be at least 9x larger in the major signal effect than the minor signal effect. *p < 
0.05; **p < 0.01; ***p < 0.002; ****p < 0.0002. All p values were calculated using Student's t-test. 
All error bars represent the 90% confidence interval estimated using 10,000 empirical bootstrap 








CHAPTER 4: PEAKS WITH SUB-ADDITIVE OR SUPER-ADDITIVE CHANGES IN 
ACCESSIBILITY ARE ASSOCIATED WITH SPECIFIC TRANSCRIPTION FACTOR MOTIFS 
 In this chapter, we show that the “special” ATAC-seq peaks that show sub-additive or 
super-additive combined responses are more likely to contain specific types of transcription factor 
motifs. We find that sub-additive peaks are generally less “motif dense” than additive or super-
additive peaks, but that they also show a strong enrichment for CTCF motifs. Super-additive 
peaks are more likely to contain SMAD motifs, and are slightly more likely than other peaks to 
contain both a retinoic acid and a TGF-β-associated transcription factor motif, suggesting that 
one possible route to super-additivity occurs through cooperative binding interactions between 
retinoic acid-induced and TGF-β-induced transcription factors.  
We used the software analysis package chromVAR to identify the transcription factor motifs most 
associated with increases or decreases in chromatin accessibility  
We wondered if the activity of particular transcription factors was associated with 
combined increases in chromatin accessibility that were either sub-additive, additive, or super-
additive. To approach this question, we first identified a set of the 50 transcription factors with the 
largest predicted changes in activity in our full set of differential peaks using the chromVAR 
package and its associated curated cisBP database of transcription factor motifs (Schep et al., 
2017). These factors included the canonical retinoic acid and TGF-β effectors RARA, SMAD3, 
SMAD4, and SMAD9, as well as forkhead box factors and ETS family factors (enriched in the 
retinoic acid condition), AP-1 factors (enriched in the TGF-β condition), and HOX and NF-κβ 
factors (enriched in both the retinoic acid and TGF-β conditions). We manually added the CTCF 
motif to this set of enriched motifs to see if putative insulators behaved differently than other cis-
regulatory elements. For each of these transcription factors, we calculated a motif enrichment 
score in each condition (based on the bias-uncorrected deviation score from chromVAR) that 
represents the percentage change in ATAC-seq fragment counts in all peaks that contain the 
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given transcription factor’s motif (Figure 10A). For example, the motif enrichment score of 0.19 for 
RARA in the retinoic acid condition means that peaks containing RARA motifs saw an average 
increase of 19% in ATAC-seq fragment counts after retinoic acid treatment (note that to decrease 
the variability of motif enrichment score estimates, we pooled together the low, medium, and high 
doses for each condition). Retinoic acid and TGF-β treatment thus led to activation of both 
distinct and shared transcription factor families, with combination treatment showing similar 
activation of distinct factors and higher activation of shared factors (Figure 10A). 
Sub-additive ATAC-seq peaks show an enrichment of CTCF motifs and a general depletion of 
other motifs  
We then tested if any of the transcription factor motifs we identified were more enriched 
in sub-additive or super-additive peaks compared to additive peaks. Because sub-additive peaks 
were on average 8% narrower and super-additive peaks were on average 36% wider than 
additive peaks (Figure 10B), we compared the number of motif matches found per 150 bp of each 
peak type. When compared to additive peaks, sub-additive peaks showed 21% fewer total motif 
matches per 150 bp in our set of enriched motifs (p = 6.6e-14) and 7% fewer total motif matches 
per 150 bp when using the entire cisBP database (p = 1.5e-8), suggesting that sub-additive 
peaks are slightly depleted for motifs overall while being even more depleted for the motifs in our 
enriched set (Figure 10C). Sub-additive peaks were especially depleted for SMARCC1 motifs 
(0.6x the motif density of additive peaks, p = 1.2e-15) as well as AP-1 subunit motifs such as JUN 
(0.6x density, p = 3.4e-13) and FOS (0.6x density, p = 6.2e-13; Figure 10E). Sub-additive peaks 
did, however, show a strong enrichment of CTCF motifs, with 1.6x and 3.2x more motif matches 
per 150 bp than in additive and super-additive peaks, respectively (p = 2.9e-11 and p < 2.2e-16, 
respectively; Figure 10E), suggesting that insulator proteins like CTCF may attenuate the 
combined activity of signal-induced transcription factors or the chromatin remodeling complexes 
they may recruit.  
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Super-additive ATAC-seq peaks show an enrichment of SMAD motifs  
Super-additive peaks generally had the same motif densities as additive peaks, with the 
exception of an increase in the density of SMAD motifs (1.8x, 1.4x, and 1.5x increase of SMAD3, 
SMAD4, and SMAD9 motif density compared to additive peaks; p = 4.4e-4, p = 8.5e-5, p = 1.5e-
5) and a depletion of several ETS family factors (0.6x the motif density of additive peaks for 
ELF1, p = 0.048; Figure 10E). The higher frequency of SMAD motifs in super-additive peaks 
suggests that SMAD transcription factors may interact with retinoic acid-induced chromatin 
remodeling factors or retinoic acid-induced transcription factors. 
We next wondered how strong of an effect each motif had on its “host” peak’s tendency 
to have a super- or sub-additive combined response. To estimate this effect, we took each motif, 
found all peaks that contained that motif that were upregulated by both TGF-β and retinoic acid 
individually, and computed the deviation from the additive prediction (d value) (Figure 10F). Here, 
we found that the presence of SMAD or NF-κβ motifs resulted in the largest increases in a peak’s 
tendency to be super-additive, possibly suggesting that SMAD proteins have one of the most 
potent interactions with a retinoic acid-induced transcription factor or chromatin remodeling 
complex in our system. Note that since we observed that both retinoic acid and TGF-β led to 
increases in NF-κβ factor activity (Figure 10A), the increase in d value associated with NF-κβ 
motifs’ could reflect synergistic activation of NF-κβ factors rather than cooperative interactions 
between NF-κβ factors and other induced transcription or chromatin remodeling factors. 
Super-additive peaks are only slightly more likely to contain a both a retinoic acid-associated 
motif and a TGF-β-associated motif 
We hypothesized that cooperative interactions between transcription factors may lead to 
super-additive increases in chromatin accessibility. To evaluate if our data supported this 
hypothesis, we tested if super-additive peaks were more likely to have both a retinoic acid-
enriched motif and a TGF-β-enriched motif. We defined retinoic acid-enriched factors to be 
retinoic acid receptor, FOX, and ETS-family factors, and we defined TGF-β-enriched motifs to be 
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SMAD, AP-1, BACH, BATF, SMARCC1, NFE2, NFE2L2, MAFF, and MAFK factors. We found 
that all categories of peaks (including super-additive) were less likely to have dual-motifs than 
expected based on a null distribution we generated by randomly shuffling motif matches across 
peaks (Figure 10D, p < 0.001 for sub-additive, additive, and super-additive peaks, see methods 
for null distribution details. The higher expected rates of dual motif matches may be explained by 
the fact that binding sites for the same transcription factor are often found in clusters (Gotea et 
al., 2010); the motif shuffling process disperses these binding sites more evenly). Super-additive 
peaks were closer to their higher expected rate than sub-additive and additive peaks (with super-
additive, additive, and sub-additive peaks having dual-motif match rates that were 10%, 21%, and 
27% lower than expected, respectively). While the effect is modest, the relatively higher rate of 
dual-motif matches in super-additive peaks provides some support for the idea that peak super-




Figure 10: Sub-additive peaks are depleted for AP-1 motifs, enriched for CTCF motifs, 
while super-additive peaks are enriched for SMAD motifs 
 
 
Figure 10: A. Motif enrichment analysis in each condition for the top 50 most variable 
transcription factor motifs identified by chromVAR. (CTCF was manually added to this set, making 
the total 51). Y-axis represents the percentage change in ATAC-seq signal at motif-containing 
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peaks compared to ethanol control samples. For each condition, we pooled together the 
replicates for each of the three dosages, resulting in nine replicates each for retinoic acid, TGF-β, 
and combination treatment. B. Average peak width of peaks upregulated individually by retinoic 
acid and TGF-β by type of combined response. C. Average motif density in each type of peak 
upregulated individually by retinoic acid and TGF-β, using the enriched motif set and the full 
cisBP database. D. Expected vs. measured percentage of dual-motif matches (one retinoic acid-
dominant motif and one TGF-β dominant motif) for each type of upregulated peak. We calculated 
the expected percentage by randomly shuffling motif matches within each peak set (see methods 
for details). Error bars represent the 5th and 95th percentile of the null distribution for expected 
percentages and the 90% bootstrapped confidence interval for measured percentages. E. Motif 
density by type of upregulated peak for each motif in our enriched set. F. For a given enriched 
motif, the median d value at medium dose for all upregulated peaks that contain the motif (higher 
d values indicate more super-additivity in peaks containing a given motif; the median d value for 
all upregulated peaks was 0.004). All error bars (except for the error bars for expected 
percentages in D) represent the 90% confidence interval estimated using 1,000 empirical 





Figure 11: Canonical retinoic acid and TGF-β signaling motifs (RARA, SMAD3, SMAD4, 
SMAD9) are enriched in their respective signal treatment conditions 
 
Figure 11: A. Motif enrichment scores for canonical retinoic acid and TGF-β effectors. The score 
reflects the average percent change in ATAC-seq fragment counts compared to ethanol control 
when a peak contains the given motif. B. chromVAR variability scores (Schep et al. 2017) for all 
870 motifs in the curated cisBP motif database for each experimental condition (Weirauch et al. 
2014). RARA had the 13th highest variability in the retinoic acid condition and SMAD3, SMAD4, 
and SMAD9 had 17th, 16th, and 14th highest chromVAR variability scores, respectively, in the 
TGF-β condition. For both panels A and B, we included all 9 ethanol controls (including low and 
high cell density controls) and all 9 replicates of each experimental condition (pooling together 




CHAPTER 5: DISCUSSION AND FUTURE DIRECTIONS 
In this thesis, I asked how cells combine the effects of retinoic acid and TGF-β to produce 
combined transcriptional and accessibility responses. In principle, the transcriptional response to 
such combinations could range over a spectrum of different possibilities, and the mechanistically-
motivated “additive” and “multiplicative” modes need not be favored. I was thus surprised to see 
that combined transcriptional responses seemed to favor the simple additive and multiplicative 
phenomenological models. 
Additive and multiplicative outcomes need not in principle be favored in any way. 
Mechanistic models of transcriptional regulation, in particular kinetic models, can yield a range of 
phenomenological predictions, spanning these two possibilities and more (Scholes et al., 2017). 
The primary reason behind the popularity of the independent recruitment model (which predicts 
additive behavior) and the thermodynamic model (which predicts multiplicative behavior) is their 
simplicity, hence our surprise. It is of course important to realize that just because the predictions 
of a particular mechanistic model match these experimental outcomes does not mean that there 
are not other models that may also match our experimental findings. Indeed, these simple 
models, which inherently posit that regulation acts via a single rate-limiting step, are incompatible 
with recent results demonstrating that regulation can act via multiple steps, and also typically 
have not been applied to complex regulatory mechanisms that involve long-range promoter-
enhancer contacts (Bartman et al., 2019; Blau et al., 1996; Fuda et al., 2009; Nechaev and 
Adelman, 2011; Stampfel et al., 2015). Further combined theoretical and experimental work 
would be required to determine the experimental signatures beyond simple additivity or 
multiplicativity that could distinguish such models from each other. 
We focused our analysis on the combined responses of genes that were individually 
upregulated by each signal. Focusing on this set of genes allowed us to develop our combined 
response factor-based analysis framework, which creates a mathematical continuum between 
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addition and multiplication and which has a readily interpretable mapping to the categories of sub-
addition, addition, multiplication, and super-multiplication. How a gene combines mixed signal 
effects (that is, when one signal increases expression of a gene and the other decreases 
expression) or two down-regulating signals was beyond the scope of our analysis, but would 
certainly be worthy of further study. These effects generally have a smaller dynamic range and 
can also lead to negative predictions when using an additive model of gene expression changes, 
and would thus benefit from new analysis frameworks other than the framework we developed in 
this thesis. Our preliminary analyses of combined transcriptional responses in genes displaying 
downregulation or mixed individual signal effects suggested that these types of combined 
responses are less likely to display additive effects and may be generally harder to predict from 
individual signal responses. In the case of combined effects at ATAC-seq peaks, it was clear in 
our preliminary analyses that downregulated or mixed effects at a peak did not generally display 
additive integration. 
Although they were the minority of cases, we did observe a large number of sub-additive 
and super-multiplicative combined responses. Super-multiplicative combined responses may 
reflect cooperative interactions between retinoic acid and TGF-β induced factors, in which binding 
of a retinoic acid factor to DNA strengthens the binding of a TGF-β factor to nearby DNA or vice 
versa. This type of interaction is consistent with our finding that super-multiplicative gene 
expression responses are associated with nearby super-additive ATAC-seq peaks (on the 
assumption that super-additivity of ATAC-seq peaks reflects cooperative binding of transcription 
factors to DNA) (Figure 9A). However, given that ATAC-seq peaks likely have additional routes to 
super-additive increases in accessibility (perhaps involving chromatin remodeling factors affected 
by our signals), further work would be needed to demonstrate that super-multiplicative 
transcriptional responses are indeed a result of direct binding interactions at enhancers. Sub-
additive transcriptional responses have been proposed to reflect saturation of cis-regulatory 
elements (Bothma et al., 2015; Scholes et al., 2019). Saturated cis-regulatory elements would in 
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principle show up as sub-additive ATAC-seq peaks in our analysis, but we did not observe an 
increase in sub-additive peaks near genes with sub-additive combined responses (with the 
exception of a small increase at high dose; Figure 9A). This lack of association suggests that 
saturation of DNA binding sites may not be sufficient to explain sub-additive combined 
transcriptional responses; instead, the sub-additive behavior may be a property specifically 
encoded through the interactions between regulatory factors. It could also be that chromatin 
accessibility does not quantitatively reflect saturating transcription factor binding. 
Our combined transcriptional responses were measured using bulk RNA-sequencing, 
which averages the transcriptional effects of retinoic acid and TGF-β across millions of cells. 
Heterogeneity in the response of individual cells could mean that what we observed, for instance, 
as a multiplicative transcriptional response at the population level is actually a mixture of sub and 
super-multiplicative transcriptional responses at the single-cell level. Future studies might 
combine microfluidic delivery of cell signals with live imaging of transcription to measure the 
response to both individual and combined signal treatments in the same single cells, thereby 
revealing the extent to which the combined response factor for a given gene displays cell-to-cell 
heterogeneity (Zhang et al. 2019). High amounts of heterogeneity could suggest a need for even 
greater flexibility in biophysical models of combined transcriptional responses. 
In our dataset, the combined response factor remained largely constant over a range of 
doses. This constancy suggests that whatever the functional interaction is between the factors 
responsible for the particular mode of combined response, that interaction is quantitatively 
maintained through doses (with some evidence for saturation at high dose). Such behavior may 
constrain potential models for interactions, because in principle the interactions could be highly 
dose dependent. Another open question is whether the mode of combined response for a 
particular gene depends on the particular signals applied or contextual factors that may vary 
between cell lines. Further studies may reveal these dependencies. In fact, differences in 
combined transcriptional responses that are solely due to differences in cell type (e.g. in an 
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isogenic background) might be a fruitful line of future inquiry, as it would allow for an analysis of 
differences in cis-regulatory element layouts that lead to changes in combined transcriptional 
responses. 
It is also unclear the extent to which the combined response factor depends on the 
duration of signal treatment; our selection of a 72-hour timepoint intentionally included the 
secondary effects of retinoic acid and TGF-β in order to generate large numbers differentially 
expressed genes to analyze. A more focused time-course study on a smaller set of genes during 
a time window that includes both primary (<3 hours) and secondary effects might reveal changes 
in individual genes’ combined response factors, as the effects of each signal begins to recruit 
additional secondary factors.  
While we find an association between super-additivity of nearby ATAC-seq peaks and 
multiplicative and super-multiplicative responses, whether there is any causality underlying this 
association remains unknown. Causality might be established in future work, which could employ 
CRISPR or CRISPRi-based methods to delete or silence regulatory elements that might be 
underlying (super-)multiplicative combined transcriptional responses. Highly-targeted deletions of 
specific motifs might preserve the individual response to one of the individual signals while 
mitigating the combination response effect.  
Another interesting feature of our data was the general lack of strong correspondence 
between changes in chromatin accessibility and changes in transcriptional output. While we were 
able to identify some trends, we could not find any strict rules for e.g. what transcription factors 
associated with what types of combined responses. We found this lack of correspondence 
surprising, given that transcription factors are the dominant form of transcriptional regulation. 
There are many potential explanations for this observation. One is that the degree of chromatin 
accessibility is not as correlated with aggregate transcription factor occupancy levels as we 
expected. For instance, it may be that accessibility may only change for some types of 
transcription factor-DNA interactions and not others. Another possibility is that our analysis does 
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not take into account precisely which peaks near a given gene correspond to regulatory elements 
and which ones do not. This mapping remains largely unknown, although information about what 
pieces of chromatin spatially contact which other ones may help narrow down the choices (Fulco 
et al., 2019; Jin et al., 2013; Rao et al., 2014; Ruf et al., 2011). Finally, it is also simply possible 
that the rules governing transcriptional output are highly complex and thus not straightforward to 
discern from the analyses we performed. In particular, it could be that the genome sequence itself 
is simply too limited to provide enough sampling of the possible configuration space of 
transcription factor binding motifs to extract meaningful rules. In future work, the use of massively 
parallel reporter assays (Kwasnieski et al., 2014; Patwardhan et al., 2012) or similar synthetic 
approaches (Bogard et al., 2019; Rosenberg et al., 2015) may help to reveal such rules and allow 
for improved estimates of transcription factor occupancy from paired chromatin accessibility and 









APPENDIX: MATERIALS AND METHODS 
Cell culture and signal delivery 
 We acquired one vial of MCF-7 cells from ATCC (lot 64125078), which we expanded in 
DMEM/F12 with 5% FBS and 1% penicillin/streptomycin. Prior to adding retinoic acid and TGF-β, 
the cells experienced a total of 13 passages and one freeze/thaw cycle. Because normal FBS 
can have significant amounts of retinoic acid (Napoli, 1986), we cultured the cells in a modified 
medium containing charcoal-stripped FBS, with each batch consisting of 50 ml charcoal-stripped 
FBS (Gemini, 100-119), 5 ml penicillin/streptomycin (Invitrogen, 15140-122), and 500 ml 
DMEM/F12 (Gibco, 10565018). We grew the MCF-7 cells in this charcoal-stripped FBS-
containing medium for a total of 70 or 71 days prior to treating them with retinoic acid and TGF-β. 
Our MCF-7 cells were negative for mycoplasma contamination after all RNA and ATAC 
sequencing experiments. 
 For our dose-response experiment, we split two ~80% confluent 10 cm dishes equally 
into 12 different 10 cm dishes, and waited 24 hours prior to adding media containing retinoic acid 
(Sigma, R2625), TGF-β (Sigma, T7039), or both signals. Because the cells grew faster when 
exposed to retinoic acid and slower when exposed to TGF-β, we included two additional control 
conditions that had 50% and 150% of the starting cell density to test for potential cell-density 
effects (these additional conditions covered the range of cell-densities seen at the endpoint of our 
experiments). We treated cells for 72 hours in three doses of retinoic acid (50nM, 200 nM, and 
400 nM), TGF-β (1.25 ng/ml, 5 ng/ml, 10 ng/ml), or both signals (50 nM retinoic acid + 1.25 ng/ml 
TGF-β, 200 nM RA + 5 ng/ml TGF-β, 400 nM RA + 10 ng/ml TGF-β). The medium dose we chose 
for TGF-β, 5 ng/ml, is used in several studies of MCF-7 cells (Mahdi et al. 2015; Noman et al. 
2017; Tian and Schiemann 2017), and the medium dose we used for retinoic acid, 200 nM, is 
between the 100 nM dose used in (Hua et al. 2009) and the 1 uM dose used in (Cunliffe et al. 
2003). All conditions had the same 0.0125% concentration of ethanol. At 72 hours, we then 
trypsinized the cells in each well, removing 50,000 of them for immediate ATAC-seq library 
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preparation and lysing the rest of them in Qiazol (storing immediately at -80°C) for subsequent 
RNA extraction and bulk RNA-seq library preparation. 
Immunofluorescence experiments and imaging 
For immunofluorescence experiments, we seeded 8-well glass chambers (Lab-tek 12-
565-470) with hormone-starved MCF-7 cells for 24 hours before treating the cells with the 
medium dose of TGF-β (5 ng/ml), retinoic acid (200 nM), or vehicle (0.0125% ethanol). Following 
treatment, we fixed cells for 12 minutes in 3.7% formaldehyde (Sigma F1635) diluted in 1x PBS. 
We stored samples at 4C in 1x PBS, then performed the immunofluorescence protocol exactly as 
described by Cell Signaling Technology, using a dilution of 1:800 for the primary anti-pSMAD2 
antibody (Cell Signaling Technology 18338T), 1:200 for the primary anti-RARA antibody (Sigma 
HPA058282), and 1:1000 for the goat anti-rabbit secondary antibody conjugated with Alexa Fluor 
647 (Thermo Fisher Scientific A-21244). In brief, we blocked samples with 5% goat serum for 60 
minutes, incubated with primary antibody overnight at 4C, washed three times with 1X PBS for 10 
minutes each, incubated with secondary antibody at room temperature for 90 minutes in the dark, 
then washed the cells another three times in 1X PBS. We stained cellular nuclei with DAPI prior 
to imaging. We imaged the cells with an inverted Nikon TI-E microscope with a 20x Plan-Apo λ 
(Nikon MRD00205) objective and with  DAPI and Atto647N filter sets. We collected all images at 
20x magnification. 
Immunofluorescence image analysis 
To quantify the nuclear pSMAD2 and RARA signal in our immunofluorescence 
experiments, we developed a custom image analysis pipeline in python that was centered around 
the usage of Cellpose (Stringer et al. 2020) to detect the nuclear boundaries of each cell. We first 
used the DAPI channel to manually select three to six high-quality images per condition. High 
quality images had minimal stacking of cells, little correlation between DAPI and 
immunofluorescence signal, and had well-focused nuclei throughout the image. We then used the 
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DAPI channel images as input to Cellpose, with an expected diameter parameter of 32 pixels. 
Using Cellpose’s identified nuclear boundaries, we then calculated the average intensity inside 
each nucleus using the corresponding immunofluorescence channel (pSMAD2 or RARA). To 
correct for differences in background, we then subtracted the average intensity of the annulus 
surrounding each nucleus in each image, using a disc-shaped structured element, the scipy 
binary_dilation function, and the nuclear mask matrix defined by Cellpose to generate the 
surrounding annulus for each nucleus. We then used this normalized nuclear intensity value for 
comparing the pSMAD2 and RARA levels between each condition. 
RNA extraction, library preparation and sequencing 
 We extracted RNA from previously frozen MCF-7 cell Qiazol lysates using the Qiagen 
miRNeasy kit (217004). We then used the NEBNext Ultra II RNA Library Prep Kit for Illumina 
(E7770) with the NEBNext Poly(A) mRNA Magnetic Isolation Module (E7490) and NEBNext 
Multiplex Oligos for Illumina (E7600) to prepare individual libraries. We then pooled our three 
replicates’ libraries together and performed paired-end sequencing on an Illumina NextSeq 500, 
using a 75-cycle NextSeq 500/550 High Output Kit v2.5 (20024906), yielding ~15 million read 
pairs per sample. 
RNA-sequencing analysis pipeline 
 We aligned reads to the hg38 assembly using STAR v2.7.1a and counted uniquely 
mapped reads with HTSeq v0.6.1 and the hg38 GTF file from Ensembl (release 90). We 
performed differential expression analysis using DESeq2 v1.22.2 (Love et al., 2014) in R 3.5.1, 
using a minimum absolute-value log-fold-change of 0.5 and a q value of 0.05. For genes with 
multiple possible transcription start sites, we used the genomic coordinates of the “canonical” 




ATAC library preparation and sequencing 
 At the endpoint of each cell condition, we immediately performed the Omni-ATAC 
protocol (Corces et al., 2017) on 50,000 live MCF-7 cells, using Illumina Tagment DNA Enzyme 
TDE1 (20034197) at the tagmentation step and double-sided bead purification at the endpoint 
with Agencourt AMPure XP magnetic beads (A63880). The exact protocol we used is available in 
the protocols folder at https://github.com/emsanford/combined_responses_paper. We then 
performed paired-end sequencing using one 75-cycle NextSeq 500/550 High Output Kit v2.5 
(20024906) for each replicate, yielding ~42 million read pairs per sample.   
ATAC-sequencing analysis 
 We created a paired-end read analysis pipeline using the ENCODE ATAC-seq v1 
pipeline specifications (available at https://www.encodeproject.org/documents/c008d7bd-5d60-
4a23-a833-67c5dfab006a/@@download/attachment/ATACSeqPipeline.pdf). Briefly, we aligned 
our ATAC-seq reads to the hg38 assembly using bowtie2 v2.3.4.1, filtered out low-quality 
alignments with samtools v1.1, removed duplicate read pairs with picard 1.96, and generated 
artificial single-ended text-based alignment files containing inferred Tn5 insertion points with 
custom python scripts and bedtools v2.25.0. To call peaks, we used MACS2 2.1.1.20160309 with 
the  command, “macs2 callpeak --nomodel --nolambda --keep-dup all --call-summits -B --SPMR --
format BED -q 0.05 --shift 75 --extsize 150”. While we created this pipeline for use on the Penn 
Medicine Academic Computing Services’ high performance cluster, it is also publicly available at 
github.com/arjunrajlaboratory/atac-seq_pipeline_paired-end. Our pipeline generates a series of 
post-sequencing quality control metrics, which we have provided in Table 1. 
 Since we had three biological replicates per ATAC-seq condition, we used an established 
“majority rule” to retain only the peak summits that were found in at least two replicates (Yang et 
al., 2014) (we used a peak size of 150 bp, centered on MACS2 summit locations, to mimic the 
span of one nucleosome). Using these condition-specific peak files, we then used bedtools to 
create one “master consensus peak file” by merging each condition’s peak summit file together in 
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a manner that disallowed overlapping peaks. We then used the number of ATAC-seq fragment 
counts at each peak in this master consensus peak file for differential peak analysis.  
 We wrote a custom peak analysis algorithm that took advantage of our additional ethanol 
control conditions to estimate a false discovery rate for differential peak identification. In this 
algorithm, we first count the number of ATAC-seq reads at each peak in the master consensus 
peak file. We then normalize the fragment counts at each peak to correct for differences in total 
sequencing depth. In this normalization step, we divide the number of reads in peaks for a given 
sample by . Then, for each condition, we calculate the 
average number of normalized read counts at each peak. Following this, we fill in an estimated 
false discovery rate in each cell of a 50x50 grid containing 50 exponentially-spaced steps of 
minimum fold-change values (ranging from 1.1 to 10) and 50 exponentially-spaced steps of 
minimum number of normalized fragment counts in the condition with the larger number of counts 
(ranging from 10 to 237). To calculate the estimated false discovery rate, we counted the number 
of differential peaks between signal-treated conditions and the normal density ethanol control as 
well as the number of differential peaks between additional ethanol controls (50% and 150% 
starting cell density) and the normal density ethanol control. We then used the average number of 
differential peaks in the additional controls to estimate the number of false positive peaks per 
experimental condition, then calculated the final estimated false discovery rate (FDR) for a given 
parameter pair using the following formula: 
 
After calculating the estimated FDR for each cell of the 50x50 grid, we then pooled 
together the differential peaks contained in any cell containing an FDR less than 0.25%. After 
pooling together the peaks in each of these cells and counting the number of differential peaks in 
the signal-treated conditions and additional controls, the combined estimated FDR was 0.65%. 
We then noticed that our original peak set’s fixed nucleosomal peak size of 150 bp led to many 
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genomic regions containing several adjacent peaks that appeared to form a single, larger peak. 
Because of this, we merged our peaks together when they were within 250 base pairs of each 
other, then we performed a second round of the same differential peak calling algorithm on the 
merged peaks, requiring a minimum fold change of 1.5 and a minimum normalized fragment 
count value of 30. In this final peak set, there are a total of 34,323 differential peaks, with a 
pooled estimated false discovery rate of 0.43%. 
 We performed motif analysis on our set of differential peaks using chromVAR v1.5.0 
(Schep et al., 2017), its associated curated cisBP database of transcription factor motifs, and the 
motifmatchR Bioconductor package. We treated each replicate as one sample for a given 
condition, and we pooled together the different dosages of the same signal(s) to decrease the 
variance of the transcription factor motif deviation scores for retinoic acid, TGF-β, and combined 
treatment. We slightly modified the chromVAR code to extract an internal metric that equals the 
fractional change in fragment counts at motif-containing peaks for a given motif.  
Statistical model for categorical classification of combined responses 
 For a given gene in a given experimental condition, we assumed that its transcripts per 
million (TPM) value for one replicate was drawn from a Gaussian distribution. We estimated the 
parameters of these Gaussian distributions to create an 80% confidence interval for which to 
compare additive and multiplicative predictions. For each dosage of the combination treatment, 
we classified a gene as sub-additive if the additive and multiplicative predictions were higher than 
the 80% confidence interval, additive if only the additive prediction laid in the confidence interval, 
multiplicative if only the multiplicative prediction laid in the interval, super-multiplicative if both 
additive and multiplicative predictions were below the confidence interval, and ambiguous if both 
the additive and the multiplicative prediction laid within the interval.  
 To estimate the mean expression value of a gene in an experimental condition (e.g., 200 
nM retinoic acid), we simply calculated the average TPM value across the three replicates. To 
improve our variance estimates, we took advantage of an observation we made during extensive 
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manual review that the coefficient of variation (CV) appeared to be the same between each 
dosage we tested for retinoic acid, TGF-β, and combined treatment (Figure 2E-F). We then 
assumed that each dosage of a condition shared one CV term, which we calculated by averaging 
each dose’s CV estimate using the unbiased estimator: 
 
Where n is the number of replicates (3 in our case), s is the sample standard deviation, and x is 
the mean of the measured TPM values, and m is the number of doses tested (3 in our case). 
Finally, we used this averaged CV estimate to estimate a variance parameter for the Gaussian 
distribution we assumed to underlie the TPM values for a given gene and signal. For a given 
gene, dosage, and signal, our final estimated Gaussian distribution was: 
 
Where  is the measured average TPM value for a given gene exposed to a 
specific dose of retinoic acid, TGF-β, or combination treatment. The benefit of using our shared 
CV term across dosages was to move from using the information from 3 samples to using the 
information from 9 samples when estimating the variances of these distributions. 
 To classify ATAC-seq peaks as sub-additive, additive, or super-additive, we used the 
same approach described above for RNA-seq TPM values, but with a given peak’s normalized 
fragment count value. We then classified peaks as sub-additive or super-additive if the additive 
prediction was higher than or lower than (respectively) the estimated Gaussian distribution’s 80% 
confidence interval. 
Statistical model for simulated additive and multiplicative predictions 
 To simulate new ATAC-seq and RNA-seq measurements, for each gene and condition 
we randomly sampled three new observations from a folded Gaussian distribution (folded to avoid 
negative expression or normalized fragment count values) with the parameters we previously 
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estimated for the purpose of categorically classifying combined response behaviors. For the 
combined treatment, we set the mean of the distribution to be either a perfectly additive or 
perfectly multiplicative prediction. We then calculated the average of the three new simulated 
observations and used these average values to determine a gene’s c value at a given dose or an 
ATAC-seq peak’s d-value at a given dose. Using this process, we calculated 250 simulated c 
values for each dose of each upregulated gene in our master set and 10 simulated d values for 
each ATAC-seq peak that was upregulated individually by retinoic acid and TGF-β. In the 
simulated data mixture model where genes can be strictly additive or multiplicative, at each we 
randomly assigned a gene to be additive or multiplicative based on the ratio of the dose-specific 
frequencies we observed in the categorical classification of the combined response. 
Use of simulated data to infer the location of a secondary peak in the observed combined 
response factor (c value) histogram 
To generate a hypothetical plot of observed c values in which the primary peak of 
additive responses centered at c = 0 was depleted, we subtracted the additive component of a c 
value histogram generated by simulated data. These simulated c values were generated using 
gene and condition-specific Gaussian distributions in a process outlined above and in Figure 2. At 
each dose, we simulated data as a mixture of additive and multiplicative combined responses, 
setting the exact proportion of simulated additive versus multiplicative combined responses based 
on the ratio of additive to multiplicative combined transcriptional responses seen at each dose of 
the observed data (Figure 1E; Figure 2B). We then scaled the size of this “mixed” simulated c 
value distribution to the peak heights at c = 0 and c = 1 in the observed c value histogram by 
minimizing the squared distance between the simulated and observed histogram bars directly 
abutting c = 0 and c = 1 (4 histogram bars total). We then subtracted the additive component of 
the simulated c value distribution and locally (in the range of c = -4 to c = 5) fit a Gaussian density 
function to the residual histogram using the nls function in R. 
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We also estimated the probability of obtaining the number of combined transcriptional 
responses in each bin of our observed c value histogram if all combined responses were additive. 
To do this, we scaled the peak height of our observed data at c = 0 to the peak height of an 
additively simulated distribution of c values. We then repeatedly (1,000 times) ran new 
simulations of additive combined responses, simulating one observation per gene in our master 
set of 1,384 genes. We used a bin width of 0.25 and allowed for overlapping bins. Because the 
probability of obtaining the observed number of counts was extremely low for many bins and 
because the variability in the number of observations in a given bin was well described by a 
Poisson distribution (outside the range of -0.3 < c < 0.3), we used a Poisson cumulative density 
function to estimate the probability of witnessing the number of observed counts (or greater) in 
each c value bin of the simulated additive data. 
Generating a null distribution for dual-motif matches 
To generate a null distribution for dual-motif matches, we first separated our set of 
upregulated peaks into sub-additive, additive, and super-additive peaks. Within these peak 
subsets, we counted the number of retinoic acid-dominant (FOX, and ETS-family factors), TGF-β-
dominant (SMAD, AP-1, BACH, BATF, SMARCC1, NFE2, NFE2L2, MAFF, and MAFK), and 
neither-signal-dominant (HOX, NFKB, CDX, CTCF, BCL, and GRHL1) motifs at each peak. Due 
to similar features of their position-weight matrices, we avoided over-counting similar motifs by 
reporting the maximum number of motif matches for a single type of motif within a group of 
motifs. The motif groups we used were as follows: retinoic acid receptor consisted of RARA, 
group FOX consisted of FOXA1, FOXA2, FOXA3, FOXC2, FOXD3; group ETS consisted of SPI, 
SPIB, SPIC, EHF, ELF1, ELF2, ELF3, ELF4, ELF5; group SMAD consisted of SMAD3, SMAD4, 
SMAD9; group AP-1 consisted of JUN, JUNB, JUND, JDP2, FOS, FOSB, FOSL1, FOSL2, 
BACH1, BACH2, BATF (note the inclusion of non-canonical AP-1 factors due to their similar motif 
position weight matrices); group SMARCC1 consisted of SMARCC1; group NFE consisted of 
NFE2, NFE2L2; group MAF consisted of MAFF, MAFK; group HOX consisted of HOXA13, 
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HOXB13, HOXC10, HOXC12, HOXC13, HOXD13; group NFKB consisted of NFKB1, REL, 
RELA; group CDX consisted of CDX1, CDX2; group CTCF consisted of CTCF; group BCL 
consisted of BCL11A, BCL11B; group GRHL1 consisted of GRHL1. For example, if a peak had 
three JUN motifs, two FOS motifs, two JDP2 motifs, and one BACH1 motif, we would count this 
as three AP-1 motifs. We then randomly shuffled these grouped motif matches within each peak 
set, with each peak retaining its original number of total motif matches (thus a peak with zero 
motif matches also had zero motif matches and a peak with four grouped motif matches always 
had four grouped motif matches after each random shuffle). After each of 1,000 random shuffles, 
we calculated the fraction of peaks in each peak set that contained both a retinoic acid-dominant 
and a TGF-β dominant motif.  
Statistical analysis 
With the exception of DESeq2’s adjusted p value and our manually calculated p value for 
the null distribution we generated for dual-motif matches at upregulated ATAC-seq peaks, we 
calculated all reported p values in the figures and main text using Welch's unequal variances t-




































control rep1 47,581,870 39,444,496 262,895,599 0.94 2.8% 11.9% 
EtOH-
control-
halfDensity rep1 41,086,622 34,396,506 250,581,572 0.95 2.4% 11.5% 
EtOH-
control-
highDensity rep1 44,072,790 36,117,206 231,669,308 0.95 4.5% 11.6% 
RA-low-
dose rep1 41,260,701 33,591,663 217,146,943 0.95 5.3% 10.7% 
RA-med-
dose rep1 31,647,052 26,123,190 179,897,280 0.95 5.8% 11.0% 
RA-high-
dose rep1 42,261,199 33,811,647 199,969,660 0.95 7.6% 11.4% 
TGF-β-low-
dose rep1 37,747,257 31,026,429 202,820,143 0.94 3.9% 10.5% 
TGF-β-
med-dose rep1 44,624,493 36,419,357 224,406,039 0.94 4.3% 10.2% 
TGF-β-
high-dose rep1 38,094,133 31,396,736 208,404,962 0.95 4.8% 10.9% 
Both-low-
dose rep1 52,387,369 40,479,658 211,802,845 0.95 10.1% 10.5% 
Both-med-
dose rep1 49,853,358 39,318,933 225,987,476 0.95 8.9% 10.5% 
Both-high-
dose rep1 42,206,009 33,786,922 204,244,183 0.95 8.1% 10.2% 
EtOH-
control rep2 38,083,282 31,779,309 226,734,741 0.94 2.5% 11.5% 
EtOH-
control-
halfDensity rep2 43,361,513 36,593,932 269,862,386 0.94 1.5% 10.6% 
EtOH-
control-
highDensity rep2 39,698,228 33,195,307 255,254,502 0.95 1.8% 11.2% 
RA-low-
dose rep2 36,715,104 30,292,869 207,792,170 0.95 4.6% 10.8% 
RA-med-
dose rep2 40,558,424 33,800,414 250,171,599 0.95 3.7% 10.4% 





dose rep2 44,817,804 36,658,961 215,298,493 0.93 3.4% 10.3% 
TGF-β-
med-dose rep2 39,929,259 33,087,956 238,242,632 0.95 3.5% 10.2% 
TGF-β-
high-dose rep2 46,205,287 38,202,058 251,952,977 0.94 2.8% 10.8% 
Both-low-
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